Bristol’s Avalide Approved For First-Line Treatment Of Hypertension
This article was originally published in The Pink Sheet Daily
Executive Summary
Therapy is indicated for use in patients “who are likely to need multiple drugs to achieve their blood pressure goals,” according to labeling.
You may also be interested in...
Avalide First-Line Indication Gets Unanimous Advisory Panel Endorsement
Some members of FDA’s Cardio-Renal Advisory Committee suggest indication could extend to moderately hypertensive patients, not just patients with severe disease.
Hologic's Adiana Permanent Birth Control Device Takes On Conceptus' Essure
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
MADIT-CRT Data Support Expanded Cardiac Resynchronization Market
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.